IMR Press / FBL / Volume 18 / Issue 4 / DOI: 10.2741/4175

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Review

BNP and NT-proBNP levels in patients with sepsis

Show Less
1 The First Hospital Affiliated to Dalian Medical University, Emergency Department, Dalian, Liaoning, 116011, China
2 The First Hospital Affiliated to Dalian Medical University, Ophthalmology Department, Dalian, Liaoning, 116011, China
Academic Editor:Fei He
Front. Biosci. (Landmark Ed) 2013, 18(4), 1237–1243; https://doi.org/10.2741/4175
Published: 1 June 2013
(This article belongs to the Special Issue Deregulation of T cell response in sepsis)
Abstract

Sepsis is a severe complication of critically ill patients that is characterized by the systemic inflammatory response syndrome (SIRS). The increased levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) are related with dysfunction of the cardiovascular system and systemic inflammation. In recent years, BNP and NT-proBNP have been the focus of studies evaluating the severity and prognosis of sepsis. In this study, we will review the role of BNP and NT-proBNP in sepsis.

Keywords
Systemic Inflammatory Response Syndrome
B-Type Natriuretic Peptide
Multiple Organ Dysfunction Syndrome
Atrial Natriuretic Peptide
Review
Share
Back to top